Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

May 31, 2020

Conditions
Asthma
Interventions
DRUG

Placebo

Intervention: Drug: placebo

DRUG

400 µg per day Beclomethasone

Intervention: Drug: Beclomethasone 400 µg HFA per day

DRUG

200 µg per day Beclomethasone

Intervention: Drug: Beclomethasone 200 µg HFA per day

DRUG

100 µg per day Beclomethasone

Intervention: Drug: Beclomethasone 100 µg HFA per day

All Listed Sponsors
lead

Adamis Pharmaceuticals Corporation

INDUSTRY

NCT03835871 - Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma | Biotech Hunter | Biotech Hunter